Literature DB >> 19586078

Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

Hans-Helmut König1, Oliver H Günther, Matthias C Angermeyer, Christiane Roick.   

Abstract

BACKGROUND: Preference-based health-state values, also referred to as utility scores, are considered an important measure of outcome in the evaluation of healthcare. A common approach to elicit utility scores is the use of the time trade-off (TTO) method; however, the data on TTO utility scores in patients with mental disorders are scarce.
OBJECTIVE: To analyse the TTO method in patients with mental disorders in terms of discriminative ability, validity and the refusal to trade life time (zero trade).
METHODS: In patients with affective (n = 172), schizophrenia spectrum (n = 166) and alcohol-related (n = 160) mental disorders, TTO utilities were administered through a standardized interview. Measures of quality of life (QOL) EQ-5D, WHOQOL-BREF, subjective (SCL-90R) and objective (CGI-S) psychopathology, and functioning (GAF, GARF, SOFAS, HoNOS) provided comparison. Discriminative ability was analysed by assessing frequency distributions of TTO utilities. Validity was analysed by assessing the correlation of TTO utilities with all other scores. The association of a patient's QOL, sociodemographic and disease-related variables with zero trade was analysed by logistic regression.
RESULTS: Of patients with affective/schizophrenic/alcohol-related mental disorders, 153/143/145 (89/86/91%), respectively, completed the TTO elicitation; 29/43/28% of the respondents were zero traders. The mean TTO utility was 0.66/0.75/0.61 and the median was 0.85/0.95/0.75. TTO utility scores discriminated well among more impaired mental health states, but discrimination was limited among less impaired health states. In patients with affective and alcohol-related mental disorders, TTO utility scores were significantly correlated (mostly moderate: 0.3 < r < 0.5) with all other scores. However, in schizophrenic patients, TTO utility scores were only a little correlated with other subjective measures and not correlated with objective measures. QOL was significantly associated with zero trade; the influence of the other variables on zero trade was negligible.
CONCLUSIONS: TTO utility scores in patients with affective or alcohol-related mental disorders were reasonably valid, but discriminative ability was compromised by a ceiling effect due to zero trade. In schizophrenic patients, validity of TTO utility scores was not demonstrated.

Entities:  

Mesh:

Year:  2009        PMID: 19586078     DOI: 10.2165/00019053-200927050-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  45 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

Review 3.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

4.  A comparison of time trade-off and quality of life measures in patients with advanced cancer.

Authors:  D J Perez; R McGee; A V Campbell; E A Christensen; S Williams
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

5.  Whose preferences count?

Authors:  P Dolan
Journal:  Med Decis Making       Date:  1999 Oct-Dec       Impact factor: 2.583

Review 6.  Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  [The regional budget for mental health care: a new approach to combine inpatient and outpatient care].

Authors:  Christiane Roick; Arno Deister; Dirk Zeichner; Thomas Birker; Hans-Helmut König; Matthias C Angermeyer
Journal:  Psychiatr Prax       Date:  2005-05

8.  Health of the Nation Outcome Scales (HoNOS). Research and development.

Authors:  J K Wing; A S Beevor; R H Curtis; S B Park; S Hadden; A Burns
Journal:  Br J Psychiatry       Date:  1998-01       Impact factor: 9.319

9.  The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.

Authors:  Oliver H Günther; Christiane Roick; Matthias C Angermeyer; Hans-Helmut König
Journal:  J Affect Disord       Date:  2007-05-29       Impact factor: 4.839

Review 10.  [Measuring preferences of psychiatric patients].

Authors:  Hans-Helmut König
Journal:  Psychiatr Prax       Date:  2004-04
View more
  12 in total

1.  Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.

Authors:  Katerina Papageorgiou; Karin M Vermeulen; Fenna R M Leijten; Erik Buskens; Adelita V Ranchor; Maya J Schroevers
Journal:  Health Expect       Date:  2014-11-13       Impact factor: 3.377

2.  Losing sight of the wood for the trees: some issues in describing and valuing health, and another possible approach.

Authors:  Paul Dolan; Henry Lee; Tessa Peasgood
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

3.  Valuing health in a racially and ethnically diverse community sample: an analysis using the valuation metrics of money and time.

Authors:  Norah E Mulvaney-Day; Marcela Horvitz-Lennon; Chih-Nan Chen; Mara Laderman; Margarita Alegría
Journal:  Qual Life Res       Date:  2010-08-01       Impact factor: 4.147

4.  The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia.

Authors:  Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo
Journal:  Qual Life Res       Date:  2011-02-03       Impact factor: 4.147

Review 5.  Time trade-off health state utility values for depression: a systematic review and meta-analysis.

Authors:  Péter György Balázs; Dalma Erdősi; Antal Zemplényi; Valentin Brodszky
Journal:  Qual Life Res       Date:  2022-09-30       Impact factor: 3.440

Review 6.  A decision analysis of long-term lithium treatment and the risk of renal failure.

Authors:  U Werneke; M Ott; E Salander Renberg; D Taylor; B Stegmayr
Journal:  Acta Psychiatr Scand       Date:  2012-03-09       Impact factor: 6.392

Review 7.  How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.

Authors:  Diana Papaioannou; John Brazier; Glenys Parry
Journal:  Value Health       Date:  2011-07-28       Impact factor: 5.725

8.  Do individuals with and without depression value depression differently? And if so, why?

Authors:  Katerina Papageorgiou; Karin M Vermeulen; Maya J Schroevers; Anne M Stiggelbout; Erik Buskens; Paul F M Krabbe; Edwin van den Heuvel; Adelita V Ranchor
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

9.  Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period.

Authors:  Holly N Essex; Ian R White; Zarnie Khadjesari; Stuart Linke; Jim McCambridge; Elizabeth Murray; Steve Parrott; Christine Godfrey
Journal:  Qual Life Res       Date:  2013-09-13       Impact factor: 4.147

10.  The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.

Authors:  Louis S Matza; Kristina S Boye; David H Feeny; Lee Bowman; Joseph A Johnston; Katie D Stewart; Kelly McDaniel; Jessica Jordan
Journal:  Eur J Health Econ       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.